Journal article
Antiplatelet therapy and coronary artery bypass grafting: a systematic review and network meta-analysis
Abstract
OBJECTIVES: Acetylsalicylic acid (ASA) monotherapy is the standard of care after coronary artery bypass grafting (CABG), but the benefits of more intense antiplatelet therapy, specifically dual antiplatelet therapy (DAPT), require further exploration in CABG patients. We performed a network meta-analysis to compare the effects of various antiplatelet regimens on saphenous vein graft patency, mortality, major adverse cardiovascular events and …
Authors
Gupta S; Belley-Cote EP; Panchal P; Pandey A; Basha A; Pallo L; Rochwerg B; Mehta S; Schwalm J-D; Whitlock RP
Journal
Interdisciplinary CardioVascular and Thoracic Surgery, Vol. 31, No. 3, pp. 354–363
Publisher
Oxford University Press (OUP)
Publication Date
September 1, 2020
DOI
10.1093/icvts/ivaa115
ISSN
1569-9293